Tuberculosis (TB):
Provider Related Resources
Recent CDC publications
-
Centers for Disease Control and
Prevention
Guidelines
for Preventing the Transmission of Mycobacterium tuberculosis in
Health-Care Settings,2005
MMWR 2005; 54 (No. RR-17,
1-141)
(Exit DHS)
-
Centers for Disease Control and
Prevention
Guidelines
for the Investigation of Contacts of Persons with Infectious
Tuberculosis: Recommendations from the National Tuberculosis
Controllers Association and CDC
MMWR 2005; 54 (No. RR-15, 1-37)
(Exit DHS)
-
Centers for Disease Control and
Prevention
Guidelines
for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium
tuberculosis Infection, United States
MMWR 2005; 54 (No. RR-15, 49-55)
(Exit DHS)
-
Centers for Disease Control and
Prevention Controlling
Tuberculosis in the United States Recommendations from the American
Thoracic Society, CDC, and the Infectious Diseases Society of America
MMWR 2005; 54 (No. RR-12)
(Exit DHS)
-
American Thoracic Society, Centers for Disease
Control and Prevention, Infectious Diseases Society of America. Treatment
of Tuberculosis
Am J Respir Crit Care Med. 2003;167:603-662
(Exit DHS)
- Centers for Disease Control and Prevention
Interactive Core
Curriculum on Tuberculosis: What the Clinician Should Know,
2004
(Exit DHS)
- American Thoracic Society and Centers for Disease Control and
Prevention
Diagnostic standards and
classification of tuberculosis in adults and children
Am. J. Respir. Crit. Care Med. 2000; 161:1376-1395
(Exit DHS)
- Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment
of latent tuberculosis infection
MMWR 2000;49(No. RR-6)
(Exit DHFS)
- Centers for Disease Control and Prevention Improving Patient Adherence to
Tuberculosis Treatment 1994
(Exit DHS)
- Tuberculosis Elimination
Revisited: Obstacles, Opportunities, and a Renewed Commitment (ACET)
Volume 48,
RR-9, August 13, 1999
(Exit DHS)
- Updated Guidelines
for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis
Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse
Transcriptase Inhibitors
MMWR 2004; 52(02);37
(Exit DHS)
- Prevention and Treatment of
Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of
Therapy and Revised Recommendations
Volume 47, RR-20, October 30, 1998
(Exit DHS)
- Recommendations for Prevention
and Control of Tuberculosis among Foreign-Born Persons
Volume 47, RR-16,
September 18, 1998
(Exit DHS)
Last Revised: July 14, 2008
|